Postpartum Hemorrhage (PPH) Devices Market By Product (Non-Pneumatic Anti-Shock Garment, Prefilled Injection System, Uterine Tamponade Devices): Global Opportunity Analysis and Industry Forecast, 2020-2030

Postpartum Hemorrhage (PPH) Devices Market

PPH is defined as the excess amount of blood loss (more than 500 ml) after the delivery of child from vagina, uterus, cervix, and perineum. Increase in incidence of pregnancy-related complications, including multiple pregnancies, inverted uterus, large baby size, surge in risk factors, which causes PPH, including uterine atony, trauma, retained placenta, and bleeding disorders, and technological advancements in the recently approved devices drive the postpartum hemorrhage devices market growth. However, lack of trained professionals and healthcare services in developing countries hampers the market growth.

Postpartum hemorrhage devices industry is segmented on the basis of on product and region. Product segment is classified into non-pneumatic anti-shock garment, prefilled injection system, and uterine tamponade device. The uterine tamponade segment is further divided into foley catheter, condom catheter, balloon tamponade, and other. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Region-wise, North America dominated the postpartum hemorrhage devices market in 2020, and is expected to be dominant during the forecast period, owing to rise in the PPH cases and availability of advanced healthcare facilities. However, Asia-Pacific is expected to register highest CAGR of 6.4% from 2021 to 2030, owing to increase in rate of anemia among women in the region, which, in turn, increases the risk of postpartum hemorrhage. In addition, rise in awareness about PPH complications and increase in healthcare expenditure fuel the growth of global PPH device market.

KEY FINDINGS OF THE STUDY

The study provides an in-depth postpartum hemorrhage devices market analysis, and the current trends & future estimations to elucidate imminent investment pockets.

By product, the uterine balloon tamponade segment accounted for the largest postpartum hemorrhage devices market share in 2020.

Region-wise, North America garnered the largest revenue share in 2020. However, Asia-Pacific is anticipated to grow at the highest CAGR during the postpartum hemorrhage devices market forecast.

Overview

Postpartum hemorrhage (PPH), defined as blood loss after vaginal or cesarean delivery, is the leading cause of maternal deaths especially in developing and under developed countries. Primary PPH is  characterized by blood loss that occurs within 24 hours of delivery and secondary PPH if the blood loss occurs after 24 hours of delivery. Poor uterine conditions, which include failure of uterus to contract after childbirth is primarily the reason for PPH and thus, the demand for modern PPH treatment devices outpace the traditional methods, due to the fact that these devices aim toward healing the uterine conditions and problems of uterus contractions.

Rise in incidence of PPH cases, increase in awareness regarding PPH risk factors, and surge in pregnancy related complications drive the growth of the market. Moreover, increase in number of education and training initiatives by the government on PPH propels the growth of this market. However, lack of awareness in developing countries about the available devices and low adoption of PPH devices in these countries restrain the growth of the market. 

Postpartum hemorrhage device market is segmented on the basis of on product and region . Product segment is classified  into non-pneumatic anti-shock garment, prefilled injection system, and uterine tamponade device. The uterine tamponade segment is fragmented into foley catheter, condom catheter, balloon tamponade, and other. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major companies profiled in this report include, 3rd Stone Design, Bactiguard AB,  Becton, Dickinson and company Clinical Innovations, LLC., Cook, Obstetrx, Organon, Path, Teleflex Incorporated, Utah Medical Products, Inc., and Zoex.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the postpartum hemorrhage devices industry, market segments, current trends, estimations, and dynamics of the postpartum hemorrhage (pph) devices market analysis from 2020 to 2030 to identify the prevailing postpartum hemorrhage devices market opportunity.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the postpartum hemorrhage (pph) devices market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global postpartum hemorrhage devices industry, market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

Clinical Innovations, LLC

Scope of Postpartum Hemorrhage (PPH) Devices Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Non-Pneumatic Anti-Shock Garment

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Prefilled Injection System

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Uterine Tamponade Devices

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key trends and opportunities

5.2.2 North America Market size and forecast, by Product

5.2.3 North America Market size and forecast, by country

5.2.3.1 U.S.

5.2.3.1.1 Market size and forecast, by Product

5.2.3.2 Canada

5.2.3.2.1 Market size and forecast, by Product

5.2.3.3 Mexico

5.2.3.3.1 Market size and forecast, by Product

5.3 Europe

5.3.1 Key trends and opportunities

5.3.2 Europe Market size and forecast, by Product

5.3.3 Europe Market size and forecast, by country

5.3.3.1 Germany

5.3.3.1.1 Market size and forecast, by Product

5.3.3.2 France

5.3.3.2.1 Market size and forecast, by Product

5.3.3.3 U.K.

5.3.3.3.1 Market size and forecast, by Product

5.3.3.4 Italy

5.3.3.4.1 Market size and forecast, by Product

5.3.3.5 Spain

5.3.3.5.1 Market size and forecast, by Product

5.3.3.6 Rest of Europe

5.3.3.6.1 Market size and forecast, by Product

5.4 Asia-Pacific

5.4.1 Key trends and opportunities

5.4.2 Asia-Pacific Market size and forecast, by Product

5.4.3 Asia-Pacific Market size and forecast, by country

5.4.3.1 Japan

5.4.3.1.1 Market size and forecast, by Product

5.4.3.2 China

5.4.3.2.1 Market size and forecast, by Product

5.4.3.3 Australia

5.4.3.3.1 Market size and forecast, by Product

5.4.3.4 India

5.4.3.4.1 Market size and forecast, by Product

5.4.3.5 South Korea

5.4.3.5.1 Market size and forecast, by Product

5.4.3.6 Rest of Asia-Pacific

5.4.3.6.1 Market size and forecast, by Product

5.5 LAMEA

5.5.1 Key trends and opportunities

5.5.2 LAMEA Market size and forecast, by Product

5.5.3 LAMEA Market size and forecast, by country

5.5.3.1 Brazil

5.5.3.1.1 Market size and forecast, by Product

5.5.3.2 Saudi Arabia

5.5.3.2.1 Market size and forecast, by Product

5.5.3.3 South Africa

5.5.3.3.1 Market size and forecast, by Product

5.5.3.4 Rest of LAMEA

5.5.3.4.1 Market size and forecast, by Product

6.1. Introduction

6.2. Top winning strategies

6.3. Product Mapping of Top 10 Player

6.4. Competitive Dashboard

6.5. Competitive Heatmap

6.6. Key developments

7.1 Utah Medical Products, Inc.

7.1.1 Company overview

7.1.2 Company snapshot

7.1.3 Operating business segments

7.1.4 Product portfolio

7.1.5 Business performance

7.1.6 Key strategic moves and developments

7.2 BD

7.2.1 Company overview

7.2.2 Company snapshot

7.2.3 Operating business segments

7.2.4 Product portfolio

7.2.5 Business performance

7.2.6 Key strategic moves and developments

7.3 Cook

7.3.1 Company overview

7.3.2 Company snapshot

7.3.3 Operating business segments

7.3.4 Product portfolio

7.3.5 Business performance

7.3.6 Key strategic moves and developments

7.4 Teleflex Incorporated

7.4.1 Company overview

7.4.2 Company snapshot

7.4.3 Operating business segments

7.4.4 Product portfolio

7.4.5 Business performance

7.4.6 Key strategic moves and developments

7.5 BACTIGUARD AB

7.5.1 Company overview

7.5.2 Company snapshot

7.5.3 Operating business segments

7.5.4 Product portfolio

7.5.5 Business performance

7.5.6 Key strategic moves and developments

7.6 PATH

7.6.1 Company overview

7.6.2 Company snapshot

7.6.3 Operating business segments

7.6.4 Product portfolio

7.6.5 Business performance

7.6.6 Key strategic moves and developments

7.7 3rd Stone Design

7.7.1 Company overview

7.7.2 Company snapshot

7.7.3 Operating business segments

7.7.4 Product portfolio

7.7.5 Business performance

7.7.6 Key strategic moves and developments

7.8 ZOEX

7.8.1 Company overview

7.8.2 Company snapshot

7.8.3 Operating business segments

7.8.4 Product portfolio

7.8.5 Business performance

7.8.6 Key strategic moves and developments

7.9 ORGANON

7.9.1 Company overview

7.9.2 Company snapshot

7.9.3 Operating business segments

7.9.4 Product portfolio

7.9.5 Business performance

7.9.6 Key strategic moves and developments

7.10 OBSTETRX

7.10.1 Company overview

7.10.2 Company snapshot

7.10.3 Operating business segments

7.10.4 Product portfolio

7.10.5 Business performance

7.10.6 Key strategic moves and developments

7.11 Clinical Innovations, LLC.

7.11.1 Company overview

7.11.2 Company snapshot

7.11.3 Operating business segments

7.11.4 Product portfolio

7.11.5 Business performance

7.11.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 2. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET REVENUE, FOR NON-PNEUMATIC ANTI-SHOCK GARMENT, BY REGION , 2020-2030,($MILLION)

TABLE 3. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET NON-PNEUMATIC ANTI-SHOCK GARMENT BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET REVENUE, FOR PREFILLED INJECTION SYSTEM, BY REGION , 2020-2030,($MILLION)

TABLE 5. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET PREFILLED INJECTION SYSTEM BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET REVENUE, FOR UTERINE TAMPONADE DEVICES, BY REGION , 2020-2030,($MILLION)

TABLE 7. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET UTERINE TAMPONADE DEVICES BY COUNTRY, 2020-2030,($MILLION)

TABLE 8. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 9. NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 10. NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 11. U.S. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 12. CANADA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 13. MEXICO POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 14. EUROPE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 15. EUROPE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 16. GERMANY POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 17. FRANCE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 18. U.K. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 19. ITALY POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 20. SPAIN POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 21. REST OF EUROPE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 22. ASIA-PACIFIC POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 23. ASIA-PACIFIC POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 24. JAPAN POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 25. CHINA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 26. AUSTRALIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 27. INDIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 28. SOUTH KOREA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 29. REST OF ASIA-PACIFIC POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 30. LAMEA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 31. LAMEA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 32. BRAZIL POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 33. SAUDI ARABIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 34. SOUTH AFRICA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 35. REST OF LAMEA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 36.UTAH MEDICAL PRODUCTS, INC.: COMPANY SNAPSHOT

TABLE 37.UTAH MEDICAL PRODUCTS, INC.: OPERATING SEGMENTS

TABLE 38.UTAH MEDICAL PRODUCTS, INC.: PRODUCT PORTFOLIO

TABLE 39.UTAH MEDICAL PRODUCTS, INC.: NET SALES,

TABLE 40.UTAH MEDICAL PRODUCTS, INC.: KEY STRATERGIES

TABLE 41.BD: COMPANY SNAPSHOT

TABLE 42.BD: OPERATING SEGMENTS

TABLE 43.BD: PRODUCT PORTFOLIO

TABLE 44.BD: NET SALES,

TABLE 45.BD: KEY STRATERGIES

TABLE 46.COOK: COMPANY SNAPSHOT

TABLE 47.COOK: OPERATING SEGMENTS

TABLE 48.COOK: PRODUCT PORTFOLIO

TABLE 49.COOK: NET SALES,

TABLE 50.COOK: KEY STRATERGIES

TABLE 51.TELEFLEX INCORPORATED: COMPANY SNAPSHOT

TABLE 52.TELEFLEX INCORPORATED: OPERATING SEGMENTS

TABLE 53.TELEFLEX INCORPORATED: PRODUCT PORTFOLIO

TABLE 54.TELEFLEX INCORPORATED: NET SALES,

TABLE 55.TELEFLEX INCORPORATED: KEY STRATERGIES

TABLE 56.BACTIGUARD AB: COMPANY SNAPSHOT

TABLE 57.BACTIGUARD AB: OPERATING SEGMENTS

TABLE 58.BACTIGUARD AB: PRODUCT PORTFOLIO

TABLE 59.BACTIGUARD AB: NET SALES,

TABLE 60.BACTIGUARD AB: KEY STRATERGIES

TABLE 61.PATH: COMPANY SNAPSHOT

TABLE 62.PATH: OPERATING SEGMENTS

TABLE 63.PATH: PRODUCT PORTFOLIO

TABLE 64.PATH: NET SALES,

TABLE 65.PATH: KEY STRATERGIES

TABLE 66.3RD STONE DESIGN: COMPANY SNAPSHOT

TABLE 67.3RD STONE DESIGN: OPERATING SEGMENTS

TABLE 68.3RD STONE DESIGN: PRODUCT PORTFOLIO

TABLE 69.3RD STONE DESIGN: NET SALES,

TABLE 70.3RD STONE DESIGN: KEY STRATERGIES

TABLE 71.ZOEX: COMPANY SNAPSHOT

TABLE 72.ZOEX: OPERATING SEGMENTS

TABLE 73.ZOEX: PRODUCT PORTFOLIO

TABLE 74.ZOEX: NET SALES,

TABLE 75.ZOEX: KEY STRATERGIES

TABLE 76.ORGANON: COMPANY SNAPSHOT

TABLE 77.ORGANON: OPERATING SEGMENTS

TABLE 78.ORGANON: PRODUCT PORTFOLIO

TABLE 79.ORGANON: NET SALES,

TABLE 80.ORGANON: KEY STRATERGIES

TABLE 81.OBSTETRX: COMPANY SNAPSHOT

TABLE 82.OBSTETRX: OPERATING SEGMENTS

TABLE 83.OBSTETRX: PRODUCT PORTFOLIO

TABLE 84.OBSTETRX: NET SALES,

TABLE 85.OBSTETRX: KEY STRATERGIES

TABLE 86.CLINICAL INNOVATIONS, LLC.: COMPANY SNAPSHOT

TABLE 87.CLINICAL INNOVATIONS, LLC.: OPERATING SEGMENTS

TABLE 88.CLINICAL INNOVATIONS, LLC.: PRODUCT PORTFOLIO

TABLE 89.CLINICAL INNOVATIONS, LLC.: NET SALES,

TABLE 90.CLINICAL INNOVATIONS, LLC.: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET SEGMENTATION

FIGURE 2.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030

FIGURE 3.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 11.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,BY PRODUCT,2020(%)

FIGURE 12.COMPARATIVE SHARE ANALYSIS OF NON-PNEUMATIC ANTI-SHOCK GARMENT POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF PREFILLED INJECTION SYSTEM POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF UTERINE TAMPONADE DEVICES POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030(%)

FIGURE 15.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY REGION,2020

FIGURE 16.U.S. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 17.CANADA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 18.MEXICO POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 19.GERMANY POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 20.FRANCE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 21.U.K. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 22.ITALY POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 23.SPAIN POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 24.REST OF EUROPE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 25.JAPAN POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 26.CHINA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 27.AUSTRALIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 28.INDIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 29.SOUTH KOREA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 30.REST OF ASIA-PACIFIC POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 31.BRAZIL POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 32.SAUDI ARABIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 33.SOUTH AFRICA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 34.REST OF LAMEA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)

FIGURE 35. TOP WINNING STRATEGIES, BY YEAR

FIGURE 36. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 37. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 38.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 39.COMPETITIVE DASHBOARD

FIGURE 40.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 41.UTAH MEDICAL PRODUCTS, INC..: NET SALES ,($MILLION)

FIGURE 42.BD.: NET SALES ,($MILLION)

FIGURE 43.COOK.: NET SALES ,($MILLION)

FIGURE 44.TELEFLEX INCORPORATED.: NET SALES ,($MILLION)

FIGURE 45.BACTIGUARD AB.: NET SALES ,($MILLION)

FIGURE 46.PATH.: NET SALES ,($MILLION)

FIGURE 47.3RD STONE DESIGN.: NET SALES ,($MILLION)

FIGURE 48.ZOEX.: NET SALES ,($MILLION)

FIGURE 49.ORGANON.: NET SALES ,($MILLION)

FIGURE 50.OBSTETRX.: NET SALES ,($MILLION)

FIGURE 51.CLINICAL INNOVATIONS, LLC..: NET SALES ,($MILLION